Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment

NCT02227238 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

627

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: DTG
DRUG: LPV/RTV
DRUG: Two NRTIs

Sponsor

ViiV Healthcare

Collaborators

[object Object]